KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Chemed (CHE) Accumulated Depreciation & Amortization (2016 - 2024)

Historic Accumulated Depreciation & Amortization for Chemed (CHE) over the last 15 years, with Q4 2024 value amounting to $382.0 million.

  • Chemed's Accumulated Depreciation & Amortization rose 764.47% to $382.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $382.0 million, marking a year-over-year increase of 764.47%. This contributed to the annual value of $382.0 million for FY2024, which is 764.47% up from last year.
  • Per Chemed's latest filing, its Accumulated Depreciation & Amortization stood at $382.0 million for Q4 2024, which was up 764.47% from $354.9 million recorded in Q4 2023.
  • In the past 5 years, Chemed's Accumulated Depreciation & Amortization registered a high of $382.0 million during Q4 2024, and its lowest value of $293.4 million during Q4 2020.
  • For the 5-year period, Chemed's Accumulated Depreciation & Amortization averaged around $336.8 million, with its median value being $335.9 million (2022).
  • In the last 5 years, Chemed's Accumulated Depreciation & Amortization skyrocketed by 860.29% in 2020 and then surged by 564.18% in 2023.
  • Chemed's Accumulated Depreciation & Amortization (Quarter) stood at $293.4 million in 2020, then increased by 8.36% to $317.9 million in 2021, then grew by 5.66% to $335.9 million in 2022, then increased by 5.64% to $354.9 million in 2023, then increased by 7.64% to $382.0 million in 2024.
  • Its Accumulated Depreciation & Amortization was $382.0 million in Q4 2024, compared to $354.9 million in Q4 2023 and $335.9 million in Q4 2022.